JAMA Network Open-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2207359, encodeId=e388220e35971, content=5.29 Quality control 5.30 Under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/30/6eac5d36269985ab3cc1e30725377771.jpg, createdBy=e12d5153196, createdName=Siutam, createdTime=Thu May 30 08:59:59 CST 2024, time=2024-05-30, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2105074, encodeId=62ff21050e446, content=想问一下各位前辈、同僚，目前under review15天了，也显示有Reviewing Editor，这种状态是送外审了吗？大约多久会有结果呢，着急用，好忧虑😢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=333, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16956388344, createdName=做梦也想sci, createdTime=Fri Dec 09 13:22:51 CST 2022, time=2022-12-09, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2206724, encodeId=88422206e241b, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：心理健康;公共卫生 经验分享：从 JAMA Psychiatry转投 Manuscript Transferred 12-14-2023 Submission Pending 12-14-2023 In Quality Control 12-14-2023 Under Review 12-15-2023 Review Complete - Decision Processed 12-18-2023 （编辑表示对稿件感兴趣，但需要语言修改后才能送外审） 语言检查修改后重新提交 Submission Pending 12-27-2023 In Quality Control 12-27-2023 Under Review 12-27-2023 Review Complete - Decision Processed 04-01-2024 （经过了漫长的4个月审稿，三个审稿人给了共十几条意见，大部分与研究方法和统计方法有关，给了三周时间修改） （修改了整整三周，重新提交） Submission Pending 04-20-2024 In Quality Control 04-20-2024 Under Review 04-20-2024 Review Complete - Decision Processed 05-15-2024 （25天后，接收） , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202405/37441fa951954102bdbd303e9119afb5-Jn5iYzVyXaae.jpg, createdBy=50048439543, createdName=ms4000001705401903, createdTime=Sun May 26 16:56:26 CST 2024, time=2024-05-26, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2193102, encodeId=616d2193102d1, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：心理健康;公共卫生 经验分享：已经77天了，还是没有消息哇, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202405/37441fa951954102bdbd303e9119afb5-Jn5iYzVyXaae.jpg, createdBy=50048439543, createdName=ms4000001705401903, createdTime=Thu Mar 14 09:45:07 CST 2024, time=2024-03-14, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2205118, encodeId=fbb1220511823, content=确实, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9c985499180, createdName=ms9000000635373725, createdTime=Thu May 16 22:50:49 CST 2024, time=2024-05-16, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=1213202, encodeId=1f491213202d7, content=审稿速度:2.0 经验分享：经验分享：编辑非常友好，审稿速度也可以，外审意见很中肯，虽然拒了 2022/02/28 Submission pending 2021/01/28 In Quality Control 2021/01/28 Under Review 2021/03/24 Review Complete - Decision Processed reject , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1232, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0e2a5469697, createdName=summer月, createdTime=Thu Apr 21 16:46:17 CST 2022, time=2022-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2137799, encodeId=6a6c213e7997e, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤;开放获取 经验分享：3.19 submission pending 3.19 in quality control 3.20 under review 4.27 review complete-Decision processed 5.9 submission pending 5.9 in quality control 5.10 under review 5.10 review complete-Decision processed 5.15 submission pending,in quality control,under review 5.18 accept 一开始投了lancet global health，本来就是投的玩的，目标还是lancet另一个17分的子刊，想着被拒再投那个，结果被拒后，人家说lancet旗下所有的杂志都不接收了。JNO是第三选择，于是乎就投了，没想到第二天就送审了。当然，那时候也没觉着能中，4月26开组会，我还说可能会拒，没想到第二天就返修，劳动节放假前一天返修，给了三个星期。休息了5天后自己修修改改，9号中午投出去，心想这不得一两周后才回复，第二天常规登陆一看，人家已经回复了，提了两个意见，一是有的作者没有完成authorship form，另一个说要确认一下某个数据。重新看了数据，回复不改后，编辑回复说会尽快回复。看了看梅斯里，今年发表的几位大哥的接收时间，大概是3天（有一位大哥是5天，但是中间有个周末），估摸着是18号回复。即便如此，也是每天都看邮箱20遍。估算时间差，应该是北京时间18号22点左右回复，这三天一直在煎熬，痛并快乐着。19号上午五点就醒了，打开手机一看：5月18日，23:50 accept 激动过程中，希望打字不是很乱，这是今年第四篇，也是人生第二高分，今年还有3篇，其中一篇已经返修，另外两篇13分和7分的希望有好消息！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=271, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8ad11919081, createdName=doctor0805, createdTime=Fri May 19 06:34:57 CST 2023, time=2023-05-19, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2128264, encodeId=f6cf21282641f, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：医学综合 经验分享：20230216：JAMA转投 20230220：Under review 20230410：审了50天，给了修回，三个审稿人 20230421：重新提交修回稿件 20230424：三天后收到编辑邮件，接收感觉因为没有with editor显示，一直under review，所以感觉比较久。审稿人提的问题很细，也和你专业。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=332, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/101296147/48BD83C5E795A6BB50E5065ABA4DCD64/100, createdBy=fd5c1979292, createdName=BRQ123, createdTime=Tue Apr 25 17:39:07 CST 2023, time=2023-04-25, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2185568, encodeId=cf1d218556844, content=审稿速度:2.0 偏重的研究方向：RCT 经验分享：23年12月初投 47天修回 小修给了三天 提交后再次修回给了三周 期待好消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=196, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=698b5472430, createdName=ms1000000314525652, createdTime=Fri Feb 02 21:46:00 CST 2024, time=2024-02-02, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2190182, encodeId=aad021901824d, content=Under review 10天，请问是送审了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=780c5321661, createdName=148ad189m02(暂无昵称), createdTime=Thu Feb 29 20:07:47 CST 2024, time=2024-02-29, status=1, ipAttribution=北京)]

2024-05-30 Siutam 来自广东省

5.29 Quality control
5.30 Under review

37 0

[GetPortalCommentsPageByObjectIdResponse(id=2207359, encodeId=e388220e35971, content=5.29 Quality control 5.30 Under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/30/6eac5d36269985ab3cc1e30725377771.jpg, createdBy=e12d5153196, createdName=Siutam, createdTime=Thu May 30 08:59:59 CST 2024, time=2024-05-30, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2105074, encodeId=62ff21050e446, content=想问一下各位前辈、同僚，目前under review15天了，也显示有Reviewing Editor，这种状态是送外审了吗？大约多久会有结果呢，着急用，好忧虑😢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=333, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16956388344, createdName=做梦也想sci, createdTime=Fri Dec 09 13:22:51 CST 2022, time=2022-12-09, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2206724, encodeId=88422206e241b, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：心理健康;公共卫生 经验分享：从 JAMA Psychiatry转投 Manuscript Transferred 12-14-2023 Submission Pending 12-14-2023 In Quality Control 12-14-2023 Under Review 12-15-2023 Review Complete - Decision Processed 12-18-2023 （编辑表示对稿件感兴趣，但需要语言修改后才能送外审） 语言检查修改后重新提交 Submission Pending 12-27-2023 In Quality Control 12-27-2023 Under Review 12-27-2023 Review Complete - Decision Processed 04-01-2024 （经过了漫长的4个月审稿，三个审稿人给了共十几条意见，大部分与研究方法和统计方法有关，给了三周时间修改） （修改了整整三周，重新提交） Submission Pending 04-20-2024 In Quality Control 04-20-2024 Under Review 04-20-2024 Review Complete - Decision Processed 05-15-2024 （25天后，接收） , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202405/37441fa951954102bdbd303e9119afb5-Jn5iYzVyXaae.jpg, createdBy=50048439543, createdName=ms4000001705401903, createdTime=Sun May 26 16:56:26 CST 2024, time=2024-05-26, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2193102, encodeId=616d2193102d1, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：心理健康;公共卫生 经验分享：已经77天了，还是没有消息哇, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202405/37441fa951954102bdbd303e9119afb5-Jn5iYzVyXaae.jpg, createdBy=50048439543, createdName=ms4000001705401903, createdTime=Thu Mar 14 09:45:07 CST 2024, time=2024-03-14, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2205118, encodeId=fbb1220511823, content=确实, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9c985499180, createdName=ms9000000635373725, createdTime=Thu May 16 22:50:49 CST 2024, time=2024-05-16, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=1213202, encodeId=1f491213202d7, content=审稿速度:2.0 经验分享：经验分享：编辑非常友好，审稿速度也可以，外审意见很中肯，虽然拒了 2022/02/28 Submission pending 2021/01/28 In Quality Control 2021/01/28 Under Review 2021/03/24 Review Complete - Decision Processed reject , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1232, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0e2a5469697, createdName=summer月, createdTime=Thu Apr 21 16:46:17 CST 2022, time=2022-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2137799, encodeId=6a6c213e7997e, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤;开放获取 经验分享：3.19 submission pending 3.19 in quality control 3.20 under review 4.27 review complete-Decision processed 5.9 submission pending 5.9 in quality control 5.10 under review 5.10 review complete-Decision processed 5.15 submission pending,in quality control,under review 5.18 accept 一开始投了lancet global health，本来就是投的玩的，目标还是lancet另一个17分的子刊，想着被拒再投那个，结果被拒后，人家说lancet旗下所有的杂志都不接收了。JNO是第三选择，于是乎就投了，没想到第二天就送审了。当然，那时候也没觉着能中，4月26开组会，我还说可能会拒，没想到第二天就返修，劳动节放假前一天返修，给了三个星期。休息了5天后自己修修改改，9号中午投出去，心想这不得一两周后才回复，第二天常规登陆一看，人家已经回复了，提了两个意见，一是有的作者没有完成authorship form，另一个说要确认一下某个数据。重新看了数据，回复不改后，编辑回复说会尽快回复。看了看梅斯里，今年发表的几位大哥的接收时间，大概是3天（有一位大哥是5天，但是中间有个周末），估摸着是18号回复。即便如此，也是每天都看邮箱20遍。估算时间差，应该是北京时间18号22点左右回复，这三天一直在煎熬，痛并快乐着。19号上午五点就醒了，打开手机一看：5月18日，23:50 accept 激动过程中，希望打字不是很乱，这是今年第四篇，也是人生第二高分，今年还有3篇，其中一篇已经返修，另外两篇13分和7分的希望有好消息！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=271, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8ad11919081, createdName=doctor0805, createdTime=Fri May 19 06:34:57 CST 2023, time=2023-05-19, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2128264, encodeId=f6cf21282641f, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：医学综合 经验分享：20230216：JAMA转投 20230220：Under review 20230410：审了50天，给了修回，三个审稿人 20230421：重新提交修回稿件 20230424：三天后收到编辑邮件，接收感觉因为没有with editor显示，一直under review，所以感觉比较久。审稿人提的问题很细，也和你专业。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=332, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/101296147/48BD83C5E795A6BB50E5065ABA4DCD64/100, createdBy=fd5c1979292, createdName=BRQ123, createdTime=Tue Apr 25 17:39:07 CST 2023, time=2023-04-25, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2185568, encodeId=cf1d218556844, content=审稿速度:2.0 偏重的研究方向：RCT 经验分享：23年12月初投 47天修回 小修给了三天 提交后再次修回给了三周 期待好消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=196, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=698b5472430, createdName=ms1000000314525652, createdTime=Fri Feb 02 21:46:00 CST 2024, time=2024-02-02, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2190182, encodeId=aad021901824d, content=Under review 10天，请问是送审了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=780c5321661, createdName=148ad189m02(暂无昵称), createdTime=Thu Feb 29 20:07:47 CST 2024, time=2024-02-29, status=1, ipAttribution=北京)]

2022-12-09 做梦也想sci 来自山东省

想问一下各位前辈、同僚，目前under review15天了，也显示有Reviewing Editor，这种状态是送外审了吗？大约多久会有结果呢，着急用，好忧虑😢

333 11

展开11条回复

[GetPortalCommentsPageByObjectIdResponse(id=2207359, encodeId=e388220e35971, content=5.29 Quality control 5.30 Under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/30/6eac5d36269985ab3cc1e30725377771.jpg, createdBy=e12d5153196, createdName=Siutam, createdTime=Thu May 30 08:59:59 CST 2024, time=2024-05-30, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2105074, encodeId=62ff21050e446, content=想问一下各位前辈、同僚，目前under review15天了，也显示有Reviewing Editor，这种状态是送外审了吗？大约多久会有结果呢，着急用，好忧虑😢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=333, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16956388344, createdName=做梦也想sci, createdTime=Fri Dec 09 13:22:51 CST 2022, time=2022-12-09, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2206724, encodeId=88422206e241b, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：心理健康;公共卫生 经验分享：从 JAMA Psychiatry转投 Manuscript Transferred 12-14-2023 Submission Pending 12-14-2023 In Quality Control 12-14-2023 Under Review 12-15-2023 Review Complete - Decision Processed 12-18-2023 （编辑表示对稿件感兴趣，但需要语言修改后才能送外审） 语言检查修改后重新提交 Submission Pending 12-27-2023 In Quality Control 12-27-2023 Under Review 12-27-2023 Review Complete - Decision Processed 04-01-2024 （经过了漫长的4个月审稿，三个审稿人给了共十几条意见，大部分与研究方法和统计方法有关，给了三周时间修改） （修改了整整三周，重新提交） Submission Pending 04-20-2024 In Quality Control 04-20-2024 Under Review 04-20-2024 Review Complete - Decision Processed 05-15-2024 （25天后，接收） , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202405/37441fa951954102bdbd303e9119afb5-Jn5iYzVyXaae.jpg, createdBy=50048439543, createdName=ms4000001705401903, createdTime=Sun May 26 16:56:26 CST 2024, time=2024-05-26, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2193102, encodeId=616d2193102d1, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：心理健康;公共卫生 经验分享：已经77天了，还是没有消息哇, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202405/37441fa951954102bdbd303e9119afb5-Jn5iYzVyXaae.jpg, createdBy=50048439543, createdName=ms4000001705401903, createdTime=Thu Mar 14 09:45:07 CST 2024, time=2024-03-14, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2205118, encodeId=fbb1220511823, content=确实, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9c985499180, createdName=ms9000000635373725, createdTime=Thu May 16 22:50:49 CST 2024, time=2024-05-16, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=1213202, encodeId=1f491213202d7, content=审稿速度:2.0 经验分享：经验分享：编辑非常友好，审稿速度也可以，外审意见很中肯，虽然拒了 2022/02/28 Submission pending 2021/01/28 In Quality Control 2021/01/28 Under Review 2021/03/24 Review Complete - Decision Processed reject , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1232, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0e2a5469697, createdName=summer月, createdTime=Thu Apr 21 16:46:17 CST 2022, time=2022-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2137799, encodeId=6a6c213e7997e, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤;开放获取 经验分享：3.19 submission pending 3.19 in quality control 3.20 under review 4.27 review complete-Decision processed 5.9 submission pending 5.9 in quality control 5.10 under review 5.10 review complete-Decision processed 5.15 submission pending,in quality control,under review 5.18 accept 一开始投了lancet global health，本来就是投的玩的，目标还是lancet另一个17分的子刊，想着被拒再投那个，结果被拒后，人家说lancet旗下所有的杂志都不接收了。JNO是第三选择，于是乎就投了，没想到第二天就送审了。当然，那时候也没觉着能中，4月26开组会，我还说可能会拒，没想到第二天就返修，劳动节放假前一天返修，给了三个星期。休息了5天后自己修修改改，9号中午投出去，心想这不得一两周后才回复，第二天常规登陆一看，人家已经回复了，提了两个意见，一是有的作者没有完成authorship form，另一个说要确认一下某个数据。重新看了数据，回复不改后，编辑回复说会尽快回复。看了看梅斯里，今年发表的几位大哥的接收时间，大概是3天（有一位大哥是5天，但是中间有个周末），估摸着是18号回复。即便如此，也是每天都看邮箱20遍。估算时间差，应该是北京时间18号22点左右回复，这三天一直在煎熬，痛并快乐着。19号上午五点就醒了，打开手机一看：5月18日，23:50 accept 激动过程中，希望打字不是很乱，这是今年第四篇，也是人生第二高分，今年还有3篇，其中一篇已经返修，另外两篇13分和7分的希望有好消息！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=271, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8ad11919081, createdName=doctor0805, createdTime=Fri May 19 06:34:57 CST 2023, time=2023-05-19, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2128264, encodeId=f6cf21282641f, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：医学综合 经验分享：20230216：JAMA转投 20230220：Under review 20230410：审了50天，给了修回，三个审稿人 20230421：重新提交修回稿件 20230424：三天后收到编辑邮件，接收感觉因为没有with editor显示，一直under review，所以感觉比较久。审稿人提的问题很细，也和你专业。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=332, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/101296147/48BD83C5E795A6BB50E5065ABA4DCD64/100, createdBy=fd5c1979292, createdName=BRQ123, createdTime=Tue Apr 25 17:39:07 CST 2023, time=2023-04-25, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2185568, encodeId=cf1d218556844, content=审稿速度:2.0 偏重的研究方向：RCT 经验分享：23年12月初投 47天修回 小修给了三天 提交后再次修回给了三周 期待好消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=196, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=698b5472430, createdName=ms1000000314525652, createdTime=Fri Feb 02 21:46:00 CST 2024, time=2024-02-02, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2190182, encodeId=aad021901824d, content=Under review 10天，请问是送审了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=780c5321661, createdName=148ad189m02(暂无昵称), createdTime=Thu Feb 29 20:07:47 CST 2024, time=2024-02-29, status=1, ipAttribution=北京)]

2024-05-26 ms4000001705401903 来自上海

审稿速度:6.0 | 投稿命中率:50.0
偏重的研究方向：心理健康;公共卫生
经验分享：从 JAMA Psychiatry转投
Manuscript Transferred 12-14-2023
Submission Pending 12-14-2023
In Quality Control 12-14-2023
Under Review 12-15-2023
Review Complete - Decision Processed 12-18-2023
（编辑表示对稿件感兴趣，但需要语言修改后才能送外审）

语言检查修改后重新提交
Submission Pending 12-27-2023
In Quality Control 12-27-2023
Under Review 12-27-2023
Review Complete - Decision Processed 04-01-2024
（经过了漫长的4个月审稿，三个审稿人给了共十几条意见，大部分与研究方法和统计方法有关，给了三周时间修改）

（修改了整整三周，重新提交）
Submission Pending 04-20-2024
In Quality Control 04-20-2024
Under Review 04-20-2024
Review Complete - Decision Processed 05-15-2024
（25天后，接收）

34 0

[GetPortalCommentsPageByObjectIdResponse(id=2207359, encodeId=e388220e35971, content=5.29 Quality control 5.30 Under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/30/6eac5d36269985ab3cc1e30725377771.jpg, createdBy=e12d5153196, createdName=Siutam, createdTime=Thu May 30 08:59:59 CST 2024, time=2024-05-30, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2105074, encodeId=62ff21050e446, content=想问一下各位前辈、同僚，目前under review15天了，也显示有Reviewing Editor，这种状态是送外审了吗？大约多久会有结果呢，着急用，好忧虑😢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=333, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16956388344, createdName=做梦也想sci, createdTime=Fri Dec 09 13:22:51 CST 2022, time=2022-12-09, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2206724, encodeId=88422206e241b, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：心理健康;公共卫生 经验分享：从 JAMA Psychiatry转投 Manuscript Transferred 12-14-2023 Submission Pending 12-14-2023 In Quality Control 12-14-2023 Under Review 12-15-2023 Review Complete - Decision Processed 12-18-2023 （编辑表示对稿件感兴趣，但需要语言修改后才能送外审） 语言检查修改后重新提交 Submission Pending 12-27-2023 In Quality Control 12-27-2023 Under Review 12-27-2023 Review Complete - Decision Processed 04-01-2024 （经过了漫长的4个月审稿，三个审稿人给了共十几条意见，大部分与研究方法和统计方法有关，给了三周时间修改） （修改了整整三周，重新提交） Submission Pending 04-20-2024 In Quality Control 04-20-2024 Under Review 04-20-2024 Review Complete - Decision Processed 05-15-2024 （25天后，接收） , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202405/37441fa951954102bdbd303e9119afb5-Jn5iYzVyXaae.jpg, createdBy=50048439543, createdName=ms4000001705401903, createdTime=Sun May 26 16:56:26 CST 2024, time=2024-05-26, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2193102, encodeId=616d2193102d1, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：心理健康;公共卫生 经验分享：已经77天了，还是没有消息哇, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202405/37441fa951954102bdbd303e9119afb5-Jn5iYzVyXaae.jpg, createdBy=50048439543, createdName=ms4000001705401903, createdTime=Thu Mar 14 09:45:07 CST 2024, time=2024-03-14, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2205118, encodeId=fbb1220511823, content=确实, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9c985499180, createdName=ms9000000635373725, createdTime=Thu May 16 22:50:49 CST 2024, time=2024-05-16, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=1213202, encodeId=1f491213202d7, content=审稿速度:2.0 经验分享：经验分享：编辑非常友好，审稿速度也可以，外审意见很中肯，虽然拒了 2022/02/28 Submission pending 2021/01/28 In Quality Control 2021/01/28 Under Review 2021/03/24 Review Complete - Decision Processed reject , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1232, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0e2a5469697, createdName=summer月, createdTime=Thu Apr 21 16:46:17 CST 2022, time=2022-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2137799, encodeId=6a6c213e7997e, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤;开放获取 经验分享：3.19 submission pending 3.19 in quality control 3.20 under review 4.27 review complete-Decision processed 5.9 submission pending 5.9 in quality control 5.10 under review 5.10 review complete-Decision processed 5.15 submission pending,in quality control,under review 5.18 accept 一开始投了lancet global health，本来就是投的玩的，目标还是lancet另一个17分的子刊，想着被拒再投那个，结果被拒后，人家说lancet旗下所有的杂志都不接收了。JNO是第三选择，于是乎就投了，没想到第二天就送审了。当然，那时候也没觉着能中，4月26开组会，我还说可能会拒，没想到第二天就返修，劳动节放假前一天返修，给了三个星期。休息了5天后自己修修改改，9号中午投出去，心想这不得一两周后才回复，第二天常规登陆一看，人家已经回复了，提了两个意见，一是有的作者没有完成authorship form，另一个说要确认一下某个数据。重新看了数据，回复不改后，编辑回复说会尽快回复。看了看梅斯里，今年发表的几位大哥的接收时间，大概是3天（有一位大哥是5天，但是中间有个周末），估摸着是18号回复。即便如此，也是每天都看邮箱20遍。估算时间差，应该是北京时间18号22点左右回复，这三天一直在煎熬，痛并快乐着。19号上午五点就醒了，打开手机一看：5月18日，23:50 accept 激动过程中，希望打字不是很乱，这是今年第四篇，也是人生第二高分，今年还有3篇，其中一篇已经返修，另外两篇13分和7分的希望有好消息！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=271, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8ad11919081, createdName=doctor0805, createdTime=Fri May 19 06:34:57 CST 2023, time=2023-05-19, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2128264, encodeId=f6cf21282641f, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：医学综合 经验分享：20230216：JAMA转投 20230220：Under review 20230410：审了50天，给了修回，三个审稿人 20230421：重新提交修回稿件 20230424：三天后收到编辑邮件，接收感觉因为没有with editor显示，一直under review，所以感觉比较久。审稿人提的问题很细，也和你专业。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=332, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/101296147/48BD83C5E795A6BB50E5065ABA4DCD64/100, createdBy=fd5c1979292, createdName=BRQ123, createdTime=Tue Apr 25 17:39:07 CST 2023, time=2023-04-25, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2185568, encodeId=cf1d218556844, content=审稿速度:2.0 偏重的研究方向：RCT 经验分享：23年12月初投 47天修回 小修给了三天 提交后再次修回给了三周 期待好消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=196, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=698b5472430, createdName=ms1000000314525652, createdTime=Fri Feb 02 21:46:00 CST 2024, time=2024-02-02, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2190182, encodeId=aad021901824d, content=Under review 10天，请问是送审了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=780c5321661, createdName=148ad189m02(暂无昵称), createdTime=Thu Feb 29 20:07:47 CST 2024, time=2024-02-29, status=1, ipAttribution=北京)]

2024-03-14 ms4000001705401903 来自上海

审稿速度:3.0 | 投稿命中率:25.0
偏重的研究方向：心理健康;公共卫生
经验分享：已经77天了，还是没有消息哇

129 6

展开6条回复

[GetPortalCommentsPageByObjectIdResponse(id=2207359, encodeId=e388220e35971, content=5.29 Quality control 5.30 Under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/30/6eac5d36269985ab3cc1e30725377771.jpg, createdBy=e12d5153196, createdName=Siutam, createdTime=Thu May 30 08:59:59 CST 2024, time=2024-05-30, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2105074, encodeId=62ff21050e446, content=想问一下各位前辈、同僚，目前under review15天了，也显示有Reviewing Editor，这种状态是送外审了吗？大约多久会有结果呢，着急用，好忧虑😢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=333, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16956388344, createdName=做梦也想sci, createdTime=Fri Dec 09 13:22:51 CST 2022, time=2022-12-09, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2206724, encodeId=88422206e241b, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：心理健康;公共卫生 经验分享：从 JAMA Psychiatry转投 Manuscript Transferred 12-14-2023 Submission Pending 12-14-2023 In Quality Control 12-14-2023 Under Review 12-15-2023 Review Complete - Decision Processed 12-18-2023 （编辑表示对稿件感兴趣，但需要语言修改后才能送外审） 语言检查修改后重新提交 Submission Pending 12-27-2023 In Quality Control 12-27-2023 Under Review 12-27-2023 Review Complete - Decision Processed 04-01-2024 （经过了漫长的4个月审稿，三个审稿人给了共十几条意见，大部分与研究方法和统计方法有关，给了三周时间修改） （修改了整整三周，重新提交） Submission Pending 04-20-2024 In Quality Control 04-20-2024 Under Review 04-20-2024 Review Complete - Decision Processed 05-15-2024 （25天后，接收） , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202405/37441fa951954102bdbd303e9119afb5-Jn5iYzVyXaae.jpg, createdBy=50048439543, createdName=ms4000001705401903, createdTime=Sun May 26 16:56:26 CST 2024, time=2024-05-26, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2193102, encodeId=616d2193102d1, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：心理健康;公共卫生 经验分享：已经77天了，还是没有消息哇, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202405/37441fa951954102bdbd303e9119afb5-Jn5iYzVyXaae.jpg, createdBy=50048439543, createdName=ms4000001705401903, createdTime=Thu Mar 14 09:45:07 CST 2024, time=2024-03-14, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2205118, encodeId=fbb1220511823, content=确实, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9c985499180, createdName=ms9000000635373725, createdTime=Thu May 16 22:50:49 CST 2024, time=2024-05-16, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=1213202, encodeId=1f491213202d7, content=审稿速度:2.0 经验分享：经验分享：编辑非常友好，审稿速度也可以，外审意见很中肯，虽然拒了 2022/02/28 Submission pending 2021/01/28 In Quality Control 2021/01/28 Under Review 2021/03/24 Review Complete - Decision Processed reject , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1232, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0e2a5469697, createdName=summer月, createdTime=Thu Apr 21 16:46:17 CST 2022, time=2022-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2137799, encodeId=6a6c213e7997e, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤;开放获取 经验分享：3.19 submission pending 3.19 in quality control 3.20 under review 4.27 review complete-Decision processed 5.9 submission pending 5.9 in quality control 5.10 under review 5.10 review complete-Decision processed 5.15 submission pending,in quality control,under review 5.18 accept 一开始投了lancet global health，本来就是投的玩的，目标还是lancet另一个17分的子刊，想着被拒再投那个，结果被拒后，人家说lancet旗下所有的杂志都不接收了。JNO是第三选择，于是乎就投了，没想到第二天就送审了。当然，那时候也没觉着能中，4月26开组会，我还说可能会拒，没想到第二天就返修，劳动节放假前一天返修，给了三个星期。休息了5天后自己修修改改，9号中午投出去，心想这不得一两周后才回复，第二天常规登陆一看，人家已经回复了，提了两个意见，一是有的作者没有完成authorship form，另一个说要确认一下某个数据。重新看了数据，回复不改后，编辑回复说会尽快回复。看了看梅斯里，今年发表的几位大哥的接收时间，大概是3天（有一位大哥是5天，但是中间有个周末），估摸着是18号回复。即便如此，也是每天都看邮箱20遍。估算时间差，应该是北京时间18号22点左右回复，这三天一直在煎熬，痛并快乐着。19号上午五点就醒了，打开手机一看：5月18日，23:50 accept 激动过程中，希望打字不是很乱，这是今年第四篇，也是人生第二高分，今年还有3篇，其中一篇已经返修，另外两篇13分和7分的希望有好消息！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=271, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8ad11919081, createdName=doctor0805, createdTime=Fri May 19 06:34:57 CST 2023, time=2023-05-19, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2128264, encodeId=f6cf21282641f, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：医学综合 经验分享：20230216：JAMA转投 20230220：Under review 20230410：审了50天，给了修回，三个审稿人 20230421：重新提交修回稿件 20230424：三天后收到编辑邮件，接收感觉因为没有with editor显示，一直under review，所以感觉比较久。审稿人提的问题很细，也和你专业。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=332, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/101296147/48BD83C5E795A6BB50E5065ABA4DCD64/100, createdBy=fd5c1979292, createdName=BRQ123, createdTime=Tue Apr 25 17:39:07 CST 2023, time=2023-04-25, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2185568, encodeId=cf1d218556844, content=审稿速度:2.0 偏重的研究方向：RCT 经验分享：23年12月初投 47天修回 小修给了三天 提交后再次修回给了三周 期待好消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=196, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=698b5472430, createdName=ms1000000314525652, createdTime=Fri Feb 02 21:46:00 CST 2024, time=2024-02-02, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2190182, encodeId=aad021901824d, content=Under review 10天，请问是送审了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=780c5321661, createdName=148ad189m02(暂无昵称), createdTime=Thu Feb 29 20:07:47 CST 2024, time=2024-02-29, status=1, ipAttribution=北京)]

2024-05-16 ms9000000635373725 来自重庆

确实

46 0

[GetPortalCommentsPageByObjectIdResponse(id=2207359, encodeId=e388220e35971, content=5.29 Quality control 5.30 Under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/30/6eac5d36269985ab3cc1e30725377771.jpg, createdBy=e12d5153196, createdName=Siutam, createdTime=Thu May 30 08:59:59 CST 2024, time=2024-05-30, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2105074, encodeId=62ff21050e446, content=想问一下各位前辈、同僚，目前under review15天了，也显示有Reviewing Editor，这种状态是送外审了吗？大约多久会有结果呢，着急用，好忧虑😢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=333, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16956388344, createdName=做梦也想sci, createdTime=Fri Dec 09 13:22:51 CST 2022, time=2022-12-09, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2206724, encodeId=88422206e241b, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：心理健康;公共卫生 经验分享：从 JAMA Psychiatry转投 Manuscript Transferred 12-14-2023 Submission Pending 12-14-2023 In Quality Control 12-14-2023 Under Review 12-15-2023 Review Complete - Decision Processed 12-18-2023 （编辑表示对稿件感兴趣，但需要语言修改后才能送外审） 语言检查修改后重新提交 Submission Pending 12-27-2023 In Quality Control 12-27-2023 Under Review 12-27-2023 Review Complete - Decision Processed 04-01-2024 （经过了漫长的4个月审稿，三个审稿人给了共十几条意见，大部分与研究方法和统计方法有关，给了三周时间修改） （修改了整整三周，重新提交） Submission Pending 04-20-2024 In Quality Control 04-20-2024 Under Review 04-20-2024 Review Complete - Decision Processed 05-15-2024 （25天后，接收） , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202405/37441fa951954102bdbd303e9119afb5-Jn5iYzVyXaae.jpg, createdBy=50048439543, createdName=ms4000001705401903, createdTime=Sun May 26 16:56:26 CST 2024, time=2024-05-26, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2193102, encodeId=616d2193102d1, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：心理健康;公共卫生 经验分享：已经77天了，还是没有消息哇, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202405/37441fa951954102bdbd303e9119afb5-Jn5iYzVyXaae.jpg, createdBy=50048439543, createdName=ms4000001705401903, createdTime=Thu Mar 14 09:45:07 CST 2024, time=2024-03-14, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2205118, encodeId=fbb1220511823, content=确实, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9c985499180, createdName=ms9000000635373725, createdTime=Thu May 16 22:50:49 CST 2024, time=2024-05-16, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=1213202, encodeId=1f491213202d7, content=审稿速度:2.0 经验分享：经验分享：编辑非常友好，审稿速度也可以，外审意见很中肯，虽然拒了 2022/02/28 Submission pending 2021/01/28 In Quality Control 2021/01/28 Under Review 2021/03/24 Review Complete - Decision Processed reject , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1232, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0e2a5469697, createdName=summer月, createdTime=Thu Apr 21 16:46:17 CST 2022, time=2022-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2137799, encodeId=6a6c213e7997e, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤;开放获取 经验分享：3.19 submission pending 3.19 in quality control 3.20 under review 4.27 review complete-Decision processed 5.9 submission pending 5.9 in quality control 5.10 under review 5.10 review complete-Decision processed 5.15 submission pending,in quality control,under review 5.18 accept 一开始投了lancet global health，本来就是投的玩的，目标还是lancet另一个17分的子刊，想着被拒再投那个，结果被拒后，人家说lancet旗下所有的杂志都不接收了。JNO是第三选择，于是乎就投了，没想到第二天就送审了。当然，那时候也没觉着能中，4月26开组会，我还说可能会拒，没想到第二天就返修，劳动节放假前一天返修，给了三个星期。休息了5天后自己修修改改，9号中午投出去，心想这不得一两周后才回复，第二天常规登陆一看，人家已经回复了，提了两个意见，一是有的作者没有完成authorship form，另一个说要确认一下某个数据。重新看了数据，回复不改后，编辑回复说会尽快回复。看了看梅斯里，今年发表的几位大哥的接收时间，大概是3天（有一位大哥是5天，但是中间有个周末），估摸着是18号回复。即便如此，也是每天都看邮箱20遍。估算时间差，应该是北京时间18号22点左右回复，这三天一直在煎熬，痛并快乐着。19号上午五点就醒了，打开手机一看：5月18日，23:50 accept 激动过程中，希望打字不是很乱，这是今年第四篇，也是人生第二高分，今年还有3篇，其中一篇已经返修，另外两篇13分和7分的希望有好消息！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=271, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8ad11919081, createdName=doctor0805, createdTime=Fri May 19 06:34:57 CST 2023, time=2023-05-19, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2128264, encodeId=f6cf21282641f, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：医学综合 经验分享：20230216：JAMA转投 20230220：Under review 20230410：审了50天，给了修回，三个审稿人 20230421：重新提交修回稿件 20230424：三天后收到编辑邮件，接收感觉因为没有with editor显示，一直under review，所以感觉比较久。审稿人提的问题很细，也和你专业。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=332, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/101296147/48BD83C5E795A6BB50E5065ABA4DCD64/100, createdBy=fd5c1979292, createdName=BRQ123, createdTime=Tue Apr 25 17:39:07 CST 2023, time=2023-04-25, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2185568, encodeId=cf1d218556844, content=审稿速度:2.0 偏重的研究方向：RCT 经验分享：23年12月初投 47天修回 小修给了三天 提交后再次修回给了三周 期待好消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=196, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=698b5472430, createdName=ms1000000314525652, createdTime=Fri Feb 02 21:46:00 CST 2024, time=2024-02-02, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2190182, encodeId=aad021901824d, content=Under review 10天，请问是送审了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=780c5321661, createdName=148ad189m02(暂无昵称), createdTime=Thu Feb 29 20:07:47 CST 2024, time=2024-02-29, status=1, ipAttribution=北京)]

2022-04-21 summer月

审稿速度:2.0
经验分享：经验分享：编辑非常友好，审稿速度也可以，外审意见很中肯，虽然拒了
2022/02/28 Submission pending
2021/01/28 In Quality Control
2021/01/28 Under Review
2021/03/24 Review Complete - Decision Processed reject

1232 20

展开20条回复

[GetPortalCommentsPageByObjectIdResponse(id=2207359, encodeId=e388220e35971, content=5.29 Quality control 5.30 Under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/30/6eac5d36269985ab3cc1e30725377771.jpg, createdBy=e12d5153196, createdName=Siutam, createdTime=Thu May 30 08:59:59 CST 2024, time=2024-05-30, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2105074, encodeId=62ff21050e446, content=想问一下各位前辈、同僚，目前under review15天了，也显示有Reviewing Editor，这种状态是送外审了吗？大约多久会有结果呢，着急用，好忧虑😢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=333, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16956388344, createdName=做梦也想sci, createdTime=Fri Dec 09 13:22:51 CST 2022, time=2022-12-09, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2206724, encodeId=88422206e241b, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：心理健康;公共卫生 经验分享：从 JAMA Psychiatry转投 Manuscript Transferred 12-14-2023 Submission Pending 12-14-2023 In Quality Control 12-14-2023 Under Review 12-15-2023 Review Complete - Decision Processed 12-18-2023 （编辑表示对稿件感兴趣，但需要语言修改后才能送外审） 语言检查修改后重新提交 Submission Pending 12-27-2023 In Quality Control 12-27-2023 Under Review 12-27-2023 Review Complete - Decision Processed 04-01-2024 （经过了漫长的4个月审稿，三个审稿人给了共十几条意见，大部分与研究方法和统计方法有关，给了三周时间修改） （修改了整整三周，重新提交） Submission Pending 04-20-2024 In Quality Control 04-20-2024 Under Review 04-20-2024 Review Complete - Decision Processed 05-15-2024 （25天后，接收） , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202405/37441fa951954102bdbd303e9119afb5-Jn5iYzVyXaae.jpg, createdBy=50048439543, createdName=ms4000001705401903, createdTime=Sun May 26 16:56:26 CST 2024, time=2024-05-26, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2193102, encodeId=616d2193102d1, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：心理健康;公共卫生 经验分享：已经77天了，还是没有消息哇, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202405/37441fa951954102bdbd303e9119afb5-Jn5iYzVyXaae.jpg, createdBy=50048439543, createdName=ms4000001705401903, createdTime=Thu Mar 14 09:45:07 CST 2024, time=2024-03-14, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2205118, encodeId=fbb1220511823, content=确实, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9c985499180, createdName=ms9000000635373725, createdTime=Thu May 16 22:50:49 CST 2024, time=2024-05-16, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=1213202, encodeId=1f491213202d7, content=审稿速度:2.0 经验分享：经验分享：编辑非常友好，审稿速度也可以，外审意见很中肯，虽然拒了 2022/02/28 Submission pending 2021/01/28 In Quality Control 2021/01/28 Under Review 2021/03/24 Review Complete - Decision Processed reject , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1232, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0e2a5469697, createdName=summer月, createdTime=Thu Apr 21 16:46:17 CST 2022, time=2022-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2137799, encodeId=6a6c213e7997e, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤;开放获取 经验分享：3.19 submission pending 3.19 in quality control 3.20 under review 4.27 review complete-Decision processed 5.9 submission pending 5.9 in quality control 5.10 under review 5.10 review complete-Decision processed 5.15 submission pending,in quality control,under review 5.18 accept 一开始投了lancet global health，本来就是投的玩的，目标还是lancet另一个17分的子刊，想着被拒再投那个，结果被拒后，人家说lancet旗下所有的杂志都不接收了。JNO是第三选择，于是乎就投了，没想到第二天就送审了。当然，那时候也没觉着能中，4月26开组会，我还说可能会拒，没想到第二天就返修，劳动节放假前一天返修，给了三个星期。休息了5天后自己修修改改，9号中午投出去，心想这不得一两周后才回复，第二天常规登陆一看，人家已经回复了，提了两个意见，一是有的作者没有完成authorship form，另一个说要确认一下某个数据。重新看了数据，回复不改后，编辑回复说会尽快回复。看了看梅斯里，今年发表的几位大哥的接收时间，大概是3天（有一位大哥是5天，但是中间有个周末），估摸着是18号回复。即便如此，也是每天都看邮箱20遍。估算时间差，应该是北京时间18号22点左右回复，这三天一直在煎熬，痛并快乐着。19号上午五点就醒了，打开手机一看：5月18日，23:50 accept 激动过程中，希望打字不是很乱，这是今年第四篇，也是人生第二高分，今年还有3篇，其中一篇已经返修，另外两篇13分和7分的希望有好消息！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=271, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8ad11919081, createdName=doctor0805, createdTime=Fri May 19 06:34:57 CST 2023, time=2023-05-19, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2128264, encodeId=f6cf21282641f, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：医学综合 经验分享：20230216：JAMA转投 20230220：Under review 20230410：审了50天，给了修回，三个审稿人 20230421：重新提交修回稿件 20230424：三天后收到编辑邮件，接收感觉因为没有with editor显示，一直under review，所以感觉比较久。审稿人提的问题很细，也和你专业。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=332, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/101296147/48BD83C5E795A6BB50E5065ABA4DCD64/100, createdBy=fd5c1979292, createdName=BRQ123, createdTime=Tue Apr 25 17:39:07 CST 2023, time=2023-04-25, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2185568, encodeId=cf1d218556844, content=审稿速度:2.0 偏重的研究方向：RCT 经验分享：23年12月初投 47天修回 小修给了三天 提交后再次修回给了三周 期待好消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=196, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=698b5472430, createdName=ms1000000314525652, createdTime=Fri Feb 02 21:46:00 CST 2024, time=2024-02-02, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2190182, encodeId=aad021901824d, content=Under review 10天，请问是送审了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=780c5321661, createdName=148ad189m02(暂无昵称), createdTime=Thu Feb 29 20:07:47 CST 2024, time=2024-02-29, status=1, ipAttribution=北京)]

2023-05-19 doctor0805 来自北京

审稿速度:2.0 | 投稿命中率:25.0
偏重的研究方向：肿瘤;开放获取
经验分享：3.19 submission pending 3.19 in quality control 3.20 under review 4.27 review complete-Decision processed 5.9 submission pending 5.9 in quality control 5.10 under review 5.10 review complete-Decision processed 5.15 submission pending,in quality control,under review 5.18 accept 一开始投了lancet global health，本来就是投的玩的，目标还是lancet另一个17分的子刊，想着被拒再投那个，结果被拒后，人家说lancet旗下所有的杂志都不接收了。JNO是第三选择，于是乎就投了，没想到第二天就送审了。当然，那时候也没觉着能中，4月26开组会，我还说可能会拒，没想到第二天就返修，劳动节放假前一天返修，给了三个星期。休息了5天后自己修修改改，9号中午投出去，心想这不得一两周后才回复，第二天常规登陆一看，人家已经回复了，提了两个意见，一是有的作者没有完成authorship form，另一个说要确认一下某个数据。重新看了数据，回复不改后，编辑回复说会尽快回复。看了看梅斯里，今年发表的几位大哥的接收时间，大概是3天（有一位大哥是5天，但是中间有个周末），估摸着是18号回复。即便如此，也是每天都看邮箱20遍。估算时间差，应该是北京时间18号22点左右回复，这三天一直在煎熬，痛并快乐着。19号上午五点就醒了，打开手机一看：5月18日，23:50 accept 激动过程中，希望打字不是很乱，这是今年第四篇，也是人生第二高分，今年还有3篇，其中一篇已经返修，另外两篇13分和7分的希望有好消息！

271 7

展开7条回复

[GetPortalCommentsPageByObjectIdResponse(id=2207359, encodeId=e388220e35971, content=5.29 Quality control 5.30 Under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/30/6eac5d36269985ab3cc1e30725377771.jpg, createdBy=e12d5153196, createdName=Siutam, createdTime=Thu May 30 08:59:59 CST 2024, time=2024-05-30, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2105074, encodeId=62ff21050e446, content=想问一下各位前辈、同僚，目前under review15天了，也显示有Reviewing Editor，这种状态是送外审了吗？大约多久会有结果呢，着急用，好忧虑😢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=333, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16956388344, createdName=做梦也想sci, createdTime=Fri Dec 09 13:22:51 CST 2022, time=2022-12-09, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2206724, encodeId=88422206e241b, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：心理健康;公共卫生 经验分享：从 JAMA Psychiatry转投 Manuscript Transferred 12-14-2023 Submission Pending 12-14-2023 In Quality Control 12-14-2023 Under Review 12-15-2023 Review Complete - Decision Processed 12-18-2023 （编辑表示对稿件感兴趣，但需要语言修改后才能送外审） 语言检查修改后重新提交 Submission Pending 12-27-2023 In Quality Control 12-27-2023 Under Review 12-27-2023 Review Complete - Decision Processed 04-01-2024 （经过了漫长的4个月审稿，三个审稿人给了共十几条意见，大部分与研究方法和统计方法有关，给了三周时间修改） （修改了整整三周，重新提交） Submission Pending 04-20-2024 In Quality Control 04-20-2024 Under Review 04-20-2024 Review Complete - Decision Processed 05-15-2024 （25天后，接收） , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202405/37441fa951954102bdbd303e9119afb5-Jn5iYzVyXaae.jpg, createdBy=50048439543, createdName=ms4000001705401903, createdTime=Sun May 26 16:56:26 CST 2024, time=2024-05-26, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2193102, encodeId=616d2193102d1, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：心理健康;公共卫生 经验分享：已经77天了，还是没有消息哇, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202405/37441fa951954102bdbd303e9119afb5-Jn5iYzVyXaae.jpg, createdBy=50048439543, createdName=ms4000001705401903, createdTime=Thu Mar 14 09:45:07 CST 2024, time=2024-03-14, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2205118, encodeId=fbb1220511823, content=确实, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9c985499180, createdName=ms9000000635373725, createdTime=Thu May 16 22:50:49 CST 2024, time=2024-05-16, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=1213202, encodeId=1f491213202d7, content=审稿速度:2.0 经验分享：经验分享：编辑非常友好，审稿速度也可以，外审意见很中肯，虽然拒了 2022/02/28 Submission pending 2021/01/28 In Quality Control 2021/01/28 Under Review 2021/03/24 Review Complete - Decision Processed reject , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1232, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0e2a5469697, createdName=summer月, createdTime=Thu Apr 21 16:46:17 CST 2022, time=2022-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2137799, encodeId=6a6c213e7997e, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤;开放获取 经验分享：3.19 submission pending 3.19 in quality control 3.20 under review 4.27 review complete-Decision processed 5.9 submission pending 5.9 in quality control 5.10 under review 5.10 review complete-Decision processed 5.15 submission pending,in quality control,under review 5.18 accept 一开始投了lancet global health，本来就是投的玩的，目标还是lancet另一个17分的子刊，想着被拒再投那个，结果被拒后，人家说lancet旗下所有的杂志都不接收了。JNO是第三选择，于是乎就投了，没想到第二天就送审了。当然，那时候也没觉着能中，4月26开组会，我还说可能会拒，没想到第二天就返修，劳动节放假前一天返修，给了三个星期。休息了5天后自己修修改改，9号中午投出去，心想这不得一两周后才回复，第二天常规登陆一看，人家已经回复了，提了两个意见，一是有的作者没有完成authorship form，另一个说要确认一下某个数据。重新看了数据，回复不改后，编辑回复说会尽快回复。看了看梅斯里，今年发表的几位大哥的接收时间，大概是3天（有一位大哥是5天，但是中间有个周末），估摸着是18号回复。即便如此，也是每天都看邮箱20遍。估算时间差，应该是北京时间18号22点左右回复，这三天一直在煎熬，痛并快乐着。19号上午五点就醒了，打开手机一看：5月18日，23:50 accept 激动过程中，希望打字不是很乱，这是今年第四篇，也是人生第二高分，今年还有3篇，其中一篇已经返修，另外两篇13分和7分的希望有好消息！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=271, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8ad11919081, createdName=doctor0805, createdTime=Fri May 19 06:34:57 CST 2023, time=2023-05-19, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2128264, encodeId=f6cf21282641f, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：医学综合 经验分享：20230216：JAMA转投 20230220：Under review 20230410：审了50天，给了修回，三个审稿人 20230421：重新提交修回稿件 20230424：三天后收到编辑邮件，接收感觉因为没有with editor显示，一直under review，所以感觉比较久。审稿人提的问题很细，也和你专业。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=332, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/101296147/48BD83C5E795A6BB50E5065ABA4DCD64/100, createdBy=fd5c1979292, createdName=BRQ123, createdTime=Tue Apr 25 17:39:07 CST 2023, time=2023-04-25, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2185568, encodeId=cf1d218556844, content=审稿速度:2.0 偏重的研究方向：RCT 经验分享：23年12月初投 47天修回 小修给了三天 提交后再次修回给了三周 期待好消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=196, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=698b5472430, createdName=ms1000000314525652, createdTime=Fri Feb 02 21:46:00 CST 2024, time=2024-02-02, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2190182, encodeId=aad021901824d, content=Under review 10天，请问是送审了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=780c5321661, createdName=148ad189m02(暂无昵称), createdTime=Thu Feb 29 20:07:47 CST 2024, time=2024-02-29, status=1, ipAttribution=北京)]

2023-04-25 BRQ123 来自上海

审稿速度:2.0 | 投稿命中率:75.0
偏重的研究方向：医学综合
经验分享：20230216：JAMA转投 20230220：Under review 20230410：审了50天，给了修回，三个审稿人 20230421：重新提交修回稿件 20230424：三天后收到编辑邮件，接收感觉因为没有with editor显示，一直under review，所以感觉比较久。审稿人提的问题很细，也和你专业。

332 8

展开8条回复

[GetPortalCommentsPageByObjectIdResponse(id=2207359, encodeId=e388220e35971, content=5.29 Quality control 5.30 Under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/30/6eac5d36269985ab3cc1e30725377771.jpg, createdBy=e12d5153196, createdName=Siutam, createdTime=Thu May 30 08:59:59 CST 2024, time=2024-05-30, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2105074, encodeId=62ff21050e446, content=想问一下各位前辈、同僚，目前under review15天了，也显示有Reviewing Editor，这种状态是送外审了吗？大约多久会有结果呢，着急用，好忧虑😢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=333, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16956388344, createdName=做梦也想sci, createdTime=Fri Dec 09 13:22:51 CST 2022, time=2022-12-09, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2206724, encodeId=88422206e241b, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：心理健康;公共卫生 经验分享：从 JAMA Psychiatry转投 Manuscript Transferred 12-14-2023 Submission Pending 12-14-2023 In Quality Control 12-14-2023 Under Review 12-15-2023 Review Complete - Decision Processed 12-18-2023 （编辑表示对稿件感兴趣，但需要语言修改后才能送外审） 语言检查修改后重新提交 Submission Pending 12-27-2023 In Quality Control 12-27-2023 Under Review 12-27-2023 Review Complete - Decision Processed 04-01-2024 （经过了漫长的4个月审稿，三个审稿人给了共十几条意见，大部分与研究方法和统计方法有关，给了三周时间修改） （修改了整整三周，重新提交） Submission Pending 04-20-2024 In Quality Control 04-20-2024 Under Review 04-20-2024 Review Complete - Decision Processed 05-15-2024 （25天后，接收） , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202405/37441fa951954102bdbd303e9119afb5-Jn5iYzVyXaae.jpg, createdBy=50048439543, createdName=ms4000001705401903, createdTime=Sun May 26 16:56:26 CST 2024, time=2024-05-26, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2193102, encodeId=616d2193102d1, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：心理健康;公共卫生 经验分享：已经77天了，还是没有消息哇, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202405/37441fa951954102bdbd303e9119afb5-Jn5iYzVyXaae.jpg, createdBy=50048439543, createdName=ms4000001705401903, createdTime=Thu Mar 14 09:45:07 CST 2024, time=2024-03-14, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2205118, encodeId=fbb1220511823, content=确实, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9c985499180, createdName=ms9000000635373725, createdTime=Thu May 16 22:50:49 CST 2024, time=2024-05-16, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=1213202, encodeId=1f491213202d7, content=审稿速度:2.0 经验分享：经验分享：编辑非常友好，审稿速度也可以，外审意见很中肯，虽然拒了 2022/02/28 Submission pending 2021/01/28 In Quality Control 2021/01/28 Under Review 2021/03/24 Review Complete - Decision Processed reject , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1232, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0e2a5469697, createdName=summer月, createdTime=Thu Apr 21 16:46:17 CST 2022, time=2022-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2137799, encodeId=6a6c213e7997e, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤;开放获取 经验分享：3.19 submission pending 3.19 in quality control 3.20 under review 4.27 review complete-Decision processed 5.9 submission pending 5.9 in quality control 5.10 under review 5.10 review complete-Decision processed 5.15 submission pending,in quality control,under review 5.18 accept 一开始投了lancet global health，本来就是投的玩的，目标还是lancet另一个17分的子刊，想着被拒再投那个，结果被拒后，人家说lancet旗下所有的杂志都不接收了。JNO是第三选择，于是乎就投了，没想到第二天就送审了。当然，那时候也没觉着能中，4月26开组会，我还说可能会拒，没想到第二天就返修，劳动节放假前一天返修，给了三个星期。休息了5天后自己修修改改，9号中午投出去，心想这不得一两周后才回复，第二天常规登陆一看，人家已经回复了，提了两个意见，一是有的作者没有完成authorship form，另一个说要确认一下某个数据。重新看了数据，回复不改后，编辑回复说会尽快回复。看了看梅斯里，今年发表的几位大哥的接收时间，大概是3天（有一位大哥是5天，但是中间有个周末），估摸着是18号回复。即便如此，也是每天都看邮箱20遍。估算时间差，应该是北京时间18号22点左右回复，这三天一直在煎熬，痛并快乐着。19号上午五点就醒了，打开手机一看：5月18日，23:50 accept 激动过程中，希望打字不是很乱，这是今年第四篇，也是人生第二高分，今年还有3篇，其中一篇已经返修，另外两篇13分和7分的希望有好消息！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=271, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8ad11919081, createdName=doctor0805, createdTime=Fri May 19 06:34:57 CST 2023, time=2023-05-19, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2128264, encodeId=f6cf21282641f, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：医学综合 经验分享：20230216：JAMA转投 20230220：Under review 20230410：审了50天，给了修回，三个审稿人 20230421：重新提交修回稿件 20230424：三天后收到编辑邮件，接收感觉因为没有with editor显示，一直under review，所以感觉比较久。审稿人提的问题很细，也和你专业。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=332, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/101296147/48BD83C5E795A6BB50E5065ABA4DCD64/100, createdBy=fd5c1979292, createdName=BRQ123, createdTime=Tue Apr 25 17:39:07 CST 2023, time=2023-04-25, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2185568, encodeId=cf1d218556844, content=审稿速度:2.0 偏重的研究方向：RCT 经验分享：23年12月初投 47天修回 小修给了三天 提交后再次修回给了三周 期待好消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=196, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=698b5472430, createdName=ms1000000314525652, createdTime=Fri Feb 02 21:46:00 CST 2024, time=2024-02-02, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2190182, encodeId=aad021901824d, content=Under review 10天，请问是送审了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=780c5321661, createdName=148ad189m02(暂无昵称), createdTime=Thu Feb 29 20:07:47 CST 2024, time=2024-02-29, status=1, ipAttribution=北京)]

2024-02-02 ms1000000314525652 来自上海

审稿速度:2.0
偏重的研究方向：RCT
经验分享：23年12月初投
47天修回
小修给了三天
提交后再次修回给了三周
期待好消息

196 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2207359, encodeId=e388220e35971, content=5.29 Quality control 5.30 Under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/30/6eac5d36269985ab3cc1e30725377771.jpg, createdBy=e12d5153196, createdName=Siutam, createdTime=Thu May 30 08:59:59 CST 2024, time=2024-05-30, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2105074, encodeId=62ff21050e446, content=想问一下各位前辈、同僚，目前under review15天了，也显示有Reviewing Editor，这种状态是送外审了吗？大约多久会有结果呢，着急用，好忧虑😢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=333, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16956388344, createdName=做梦也想sci, createdTime=Fri Dec 09 13:22:51 CST 2022, time=2022-12-09, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2206724, encodeId=88422206e241b, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：心理健康;公共卫生 经验分享：从 JAMA Psychiatry转投 Manuscript Transferred 12-14-2023 Submission Pending 12-14-2023 In Quality Control 12-14-2023 Under Review 12-15-2023 Review Complete - Decision Processed 12-18-2023 （编辑表示对稿件感兴趣，但需要语言修改后才能送外审） 语言检查修改后重新提交 Submission Pending 12-27-2023 In Quality Control 12-27-2023 Under Review 12-27-2023 Review Complete - Decision Processed 04-01-2024 （经过了漫长的4个月审稿，三个审稿人给了共十几条意见，大部分与研究方法和统计方法有关，给了三周时间修改） （修改了整整三周，重新提交） Submission Pending 04-20-2024 In Quality Control 04-20-2024 Under Review 04-20-2024 Review Complete - Decision Processed 05-15-2024 （25天后，接收） , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202405/37441fa951954102bdbd303e9119afb5-Jn5iYzVyXaae.jpg, createdBy=50048439543, createdName=ms4000001705401903, createdTime=Sun May 26 16:56:26 CST 2024, time=2024-05-26, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2193102, encodeId=616d2193102d1, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：心理健康;公共卫生 经验分享：已经77天了，还是没有消息哇, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202405/37441fa951954102bdbd303e9119afb5-Jn5iYzVyXaae.jpg, createdBy=50048439543, createdName=ms4000001705401903, createdTime=Thu Mar 14 09:45:07 CST 2024, time=2024-03-14, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2205118, encodeId=fbb1220511823, content=确实, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9c985499180, createdName=ms9000000635373725, createdTime=Thu May 16 22:50:49 CST 2024, time=2024-05-16, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=1213202, encodeId=1f491213202d7, content=审稿速度:2.0 经验分享：经验分享：编辑非常友好，审稿速度也可以，外审意见很中肯，虽然拒了 2022/02/28 Submission pending 2021/01/28 In Quality Control 2021/01/28 Under Review 2021/03/24 Review Complete - Decision Processed reject , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1232, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0e2a5469697, createdName=summer月, createdTime=Thu Apr 21 16:46:17 CST 2022, time=2022-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2137799, encodeId=6a6c213e7997e, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤;开放获取 经验分享：3.19 submission pending 3.19 in quality control 3.20 under review 4.27 review complete-Decision processed 5.9 submission pending 5.9 in quality control 5.10 under review 5.10 review complete-Decision processed 5.15 submission pending,in quality control,under review 5.18 accept 一开始投了lancet global health，本来就是投的玩的，目标还是lancet另一个17分的子刊，想着被拒再投那个，结果被拒后，人家说lancet旗下所有的杂志都不接收了。JNO是第三选择，于是乎就投了，没想到第二天就送审了。当然，那时候也没觉着能中，4月26开组会，我还说可能会拒，没想到第二天就返修，劳动节放假前一天返修，给了三个星期。休息了5天后自己修修改改，9号中午投出去，心想这不得一两周后才回复，第二天常规登陆一看，人家已经回复了，提了两个意见，一是有的作者没有完成authorship form，另一个说要确认一下某个数据。重新看了数据，回复不改后，编辑回复说会尽快回复。看了看梅斯里，今年发表的几位大哥的接收时间，大概是3天（有一位大哥是5天，但是中间有个周末），估摸着是18号回复。即便如此，也是每天都看邮箱20遍。估算时间差，应该是北京时间18号22点左右回复，这三天一直在煎熬，痛并快乐着。19号上午五点就醒了，打开手机一看：5月18日，23:50 accept 激动过程中，希望打字不是很乱，这是今年第四篇，也是人生第二高分，今年还有3篇，其中一篇已经返修，另外两篇13分和7分的希望有好消息！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=271, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8ad11919081, createdName=doctor0805, createdTime=Fri May 19 06:34:57 CST 2023, time=2023-05-19, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2128264, encodeId=f6cf21282641f, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：医学综合 经验分享：20230216：JAMA转投 20230220：Under review 20230410：审了50天，给了修回，三个审稿人 20230421：重新提交修回稿件 20230424：三天后收到编辑邮件，接收感觉因为没有with editor显示，一直under review，所以感觉比较久。审稿人提的问题很细，也和你专业。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=332, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/101296147/48BD83C5E795A6BB50E5065ABA4DCD64/100, createdBy=fd5c1979292, createdName=BRQ123, createdTime=Tue Apr 25 17:39:07 CST 2023, time=2023-04-25, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2185568, encodeId=cf1d218556844, content=审稿速度:2.0 偏重的研究方向：RCT 经验分享：23年12月初投 47天修回 小修给了三天 提交后再次修回给了三周 期待好消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=196, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=698b5472430, createdName=ms1000000314525652, createdTime=Fri Feb 02 21:46:00 CST 2024, time=2024-02-02, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2190182, encodeId=aad021901824d, content=Under review 10天，请问是送审了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=780c5321661, createdName=148ad189m02(暂无昵称), createdTime=Thu Feb 29 20:07:47 CST 2024, time=2024-02-29, status=1, ipAttribution=北京)]

2024-02-29 148ad189m02(暂无昵称) 来自北京

Under review 10天，请问是送审了吗

141 3

展开3条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务